{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:53:09Z","timestamp":1781592789324,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.biopha.2018.01.019","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T19:04:11Z","timestamp":1515438251000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Down-regulation of miR-133a\/b in patients with myocardial infarction correlates with the presence of ventricular fibrillation"],"prefix":"10.1016","volume":"99","author":[{"given":"Emanuela","family":"Bo\u0161tjan\u010di\u010d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanisa","family":"Brandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Zidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damjan","family":"Glava\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161an","family":"\u0160tajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.01.019_bib0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/cvr\/cvn181","article-title":"Control of cardiac excitability by microRNAs","volume":"79","author":"Yang","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2018.01.019_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yjmcc.2016.03.015","article-title":"Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction)","volume":"94","author":"Chistiakov","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2018.01.019_bib0015","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/CIRCRESAHA.108.183087","article-title":"The emerging role of microRNAs in cardiac remodeling and heart failure","volume":"103","author":"Divakaran","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2018.01.019_bib0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1540-8167.2008.01357.x","article-title":"RNA silencing: small RNA-mediated posttranscriptional regulation of mRNA and the implications for heart electropathophysiology","volume":"20","author":"Latronico","year":"2009","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.biopha.2018.01.019_bib0025","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/FJC.0b013e3181edb22c","article-title":"The role of microRNA in cardiac excitability","volume":"56","author":"Wang","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.019_bib0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000315076","article-title":"Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications","volume":"25","author":"Luo","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2018.01.019_bib0035","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1039\/C4MB00338A","article-title":"miRNA-1: functional roles and dysregulation in heart disease","volume":"10","author":"Duan","year":"2014","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.biopha.2018.01.019_bib0040","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1389450115666140627104151","article-title":"microRNA-133: expression, function and therapeutic potential in muscle diseases and cancer","volume":"15","author":"Yu","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biopha.2018.01.019_bib0045","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1172\/JCI36154","article-title":"MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice","volume":"119","author":"Callis","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2018.01.019_bib0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/dna.2012.1787","article-title":"The emerging role of miR-208a in the heart","volume":"32","author":"Oliveira-Carvalho","year":"2013","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.biopha.2018.01.019_bib0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.yjmcc.2014.10.001","article-title":"Detailed characterization of microRNA changes in a canine heart failure model: relationship to arrhythmogenic structural remodeling","volume":"77","author":"Chen","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2018.01.019_bib0060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4330\/wjc.v6.i9.939","article-title":"miRNome in myocardial infarction: future directions and perspective","volume":"6","author":"Bo\u0161tjan\u010di\u010d","year":"2014","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.biopha.2018.01.019_bib0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.lfs.2010.11.022","article-title":"miRNAs got rhythm","volume":"88","author":"Elton","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2018.01.019_bib0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000268088","article-title":"MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction","volume":"115","author":"Bo\u0161tjan\u010di\u010d","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.biopha.2018.01.019_bib0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14712\/fb2010056010027","article-title":"MicroRNA miR-1 is up-regulated in remote myocardium in patients with myocardial infarction","volume":"56","author":"Bo\u0161tjan\u010di\u010d","year":"2010","journal-title":"Folia Biol. (Praha)"},{"key":"10.1016\/j.biopha.2018.01.019_bib0080","doi-asserted-by":"crossref","first-page":"e0129338","DOI":"10.1371\/journal.pone.0129338","article-title":"MicroRNA stability in postmortem FFPE tissues: quantitative analysis using autoptic samples from acute myocardial infarction patients","volume":"10","author":"Kakimoto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.01.019_bib0085","series-title":"Applied Biosystems Application Note","article-title":"Endogenous controls for real-time quantitation of miRNA using TaqMan MicroRNA assays","author":"Wong","year":"2010"},{"key":"10.1016\/j.biopha.2018.01.019_bib0090","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2018.01.019_bib0095","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.3892\/mmr.2015.3831","article-title":"Altered expression of hyperpolarization-activated cyclic nucleotide-gated channels and microRNA-1 and -133 in patients with age-associated atrial fibrillation","volume":"12","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2018.01.019_bib0100","doi-asserted-by":"crossref","first-page":"20045","DOI":"10.1074\/jbc.M801035200","article-title":"Down-regulation of miR-1\/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart","volume":"283","author":"Luo","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.01.019_bib0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jcp.21062","article-title":"Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4","volume":"212","author":"Xiao","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2018.01.019_bib0110","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1476-5381.2011.01627.x","article-title":"Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression","volume":"165","author":"Suffredini","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.019_bib0115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nm1569","article-title":"The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2","volume":"13","author":"Yang","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2018.01.019_bib0120","doi-asserted-by":"crossref","first-page":"e70158","DOI":"10.1371\/journal.pone.0070158","article-title":"MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts","volume":"8","author":"Curcio","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.01.019_bib0125","doi-asserted-by":"crossref","first-page":"e28324","DOI":"10.1371\/journal.pone.0028324","article-title":"MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex","volume":"6","author":"Belevych","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.01.019_bib0130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/cvr\/cvp232","article-title":"MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection","volume":"84","author":"Lu","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2018.01.019_bib0135","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1476-5381.2009.00377.x","article-title":"Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1","volume":"158","author":"Shan","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.019_bib0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2016.02.145","article-title":"MicroRNA deep sequencing reveals chamber-specific miR-208 family expression patterns in the human heart","volume":"211","author":"Kakimoto","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2018.01.019_bib0145","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCRESAHA.109.202176","article-title":"MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts","volume":"106","author":"Matkovich","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2018.01.019_bib0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvs196","article-title":"Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly","volume":"95","author":"Ai","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2018.01.019_bib0155","doi-asserted-by":"crossref","first-page":"e0160920","DOI":"10.1371\/journal.pone.0160920","article-title":"Differential microRNA expression and regulation in the rat model of post-infarction heart failure","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.01.019_bib0160","first-page":"679","article-title":"MicroRNA-208a increases myocardial endoglin expression and myocardial fibrosis in acute myocardial infarction","volume":"31","author":"Shyu","year":"2015","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2018.01.019_bib0165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.1139089","article-title":"Control of stress-dependent cardiac growth and gene expression by a microRNA","volume":"316","author":"van Rooij","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.01.019_bib0170","doi-asserted-by":"crossref","first-page":"479123","DOI":"10.1155\/2015\/479123","article-title":"MicroRNA-208a dysregulates apoptosis genes expression and promotes cardiomyocyte apoptosis during ischemia and its silencing improves cardiac function after myocardial infarction","volume":"9","author":"Tony","year":"2015","journal-title":"Mediators Inflamm."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217332870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217332870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:14:14Z","timestamp":1781590454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217332870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":34,"alternative-id":["S0753332217332870"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.019","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Down-regulation of miR-133a\/b in patients with myocardial infarction correlates with the presence of ventricular fibrillation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}